Solve Therapeutics has completed a $120 million unlabelled round as it advances a pair of antibody-drug conjugates (ADCs) for cancer that use its proprietary linker technology. San Diego-based Solve ...
Since the launch of the Crossword in 1942, The Times has captivated solvers by providing engaging word and logic games. In 2014, we introduced the Mini Crossword — followed by Spelling Bee, Letter ...
Something went wrong. Try again, or contact support if the problem persists. Your details are incorrect, or aren't in our system yet. Please try again, or sign up if you're new here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results